We are live on ! Find out more
BM

Bridger Management Portfolio holdings

AUM $150M
1-Year Est. Return 17.71%
This Fund
S&P 500
This Quarter Est. Return
+8.36%
1 Year Est. Return
+17.71%
3 Year Est. Return
+103.24%
5 Year Est. Return
+155.85%
10 Year Est. Return
+1,056.65%
AUM
$3.16B
AUM Growth
+$1.67B
Cap. Flow
+$130M
Cap. Flow %
4.1%
Top 10 Hldgs %
65.71%
Holding
52
New
14
Increased
12
Reduced
13
Closed
8

Top Buys

Rank Stock Value
1
BCC icon
Boise Cascade
BCC
+$61.5M
2
PODD icon
Insulet
PODD
+$53.2M
3
CI icon
Cigna
CI
+$46.5M
4
EXAS
Exact Sciences
EXAS
+$38.7M
5
MGM icon
MGM Resorts International
MGM
+$37.1M

Top Sells

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$71.4M
2
ARAY icon
Accuray
ARAY
+$36.3M
3
ZTS icon
Zoetis
ZTS
+$27.2M
4
THC icon
Tenet Healthcare
THC
+$26.1M
5
TEVA icon
Teva Pharmaceutical Industries Limited
TEVA
+$25.3M

Sector Composition

Rank Sector Weight
1 Miscellaneous 48.09%
2 Healthcare 32.55%
3 Consumer Discretionary 4.58%
4 Communication Services 3.49%
5 Consumer Staples 2.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFSI icon
26
PennyMac Financial
PFSI
$3.52B
$33.1M 1.05%
1,826,960
-198,040
-10% -$3.61M
HUM icon
27
Humana
HUM
$46.9B
$32.3M 1.02%
168,809
-132,415
-44% -$24.6M
CRDF icon
28
Cardiff Oncology
CRDF
$107M
$32M 1.01%
43,758
+4,167
+11% +$2.96M
IRWD icon
29
Ironwood Pharmaceuticals
IRWD
$676M
$30.3M 0.96%
2,997,003
+1,993,471
+199% +$23.2M
CNC icon
30
Centene
CNC
$33.8B
$29.9M 0.95%
744,196
-312,156
-30% -$11.2M
LLY icon
31
Eli Lilly
LLY
$1.02T
$29.2M 0.92%
349,591
-17,302
-5% -$1.32M
REGN icon
32
Regeneron Pharmaceuticals
REGN
$79.9B
$27.6M 0.87%
+54,132
New +$26.4M
ATRA icon
33
Atara Biotherapeutics
ATRA
$96.9M
$26.4M 0.84%
20,052
+1,059
+6% +$1.21M
TGTX icon
34
TG Therapeutics
TGTX
$8.6B
$25.5M 0.81%
1,537,529
-514,292
-25% -$8.14M
LBRDA
35
DELISTED
Liberty Broadband Class A
LBRDA
$17.6M 0.56%
+345,680
New +$18.4M
AMLP icon
36
CALL
Alerian MLP ETF
AMLP
$13.4B
$15.6M 0.49%
200,000
– –
DYAX
37
DELISTED
DYAX CORPORATION
DYAX
$13.9M 0.44%
+523,157
New +$13.9M
CCJ icon
38
Cameco
CCJ
$40B
$11.6M 0.37%
813,586
– –
AMRI
39
DELISTED
Albany Molecular Research Inc
AMRI
$11.3M 0.36%
558,818
+158,762
+40% +$3.06M
SGYP
40
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$7.03M 0.22%
+847,094
New +$4.11M
BKI
41
DELISTED
Black Knight, Inc. Common Stock
BKI
$6.66M 0.21%
+215,700
New +$6.23M
LXRX icon
42
Lexicon Pharmaceuticals
LXRX
$908M
$2.09M 0.07%
+259,458
New +$1.91M
RGDX
43
DELISTED
RESPONSE GENETICS, INC COMMON SHS (DELAWARE)
RGDX
$1.96M 0.06%
6,000,000
– –
ALPN
44
DELISTED
Alpine Immune Sciences Inc
ALPN
$452K 0.01%
+8,290
New +$494K
ARAY icon
45
Accuray
ARAY
$28M
– –
-3,903,090
Closed -$36.3M
ARWR icon
46
Arrowhead Research
ARWR
$9.6B
– –
-2,976,183
Closed -$20.1M
CWST icon
47
Casella Waste Systems
CWST
$5.86B
– –
-544,220
Closed -$2.99M
MS icon
48
Morgan Stanley
MS
$323B
– –
-2,000,000
Closed -$71.4M
TEVA icon
49
Teva Pharmaceutical Industries Limited
TEVA
$45.5B
– –
-406,756
Closed -$25.3M
THC icon
50
Tenet Healthcare
THC
$21.3B
– –
-527,088
Closed -$26.1M
1
2
3

Similar funds

KCM
Kennondale Capital Management Richmond, Virginia $150M AUM 46.45% 1-Year Est. Return
NMCM
Nicholson Meyer Capital Management Kansas City, Missouri $150M AUM 27.66% 1-Year Est. Return
IVGAI
Index Venture Growth Associates III St. Helier, Channel Islands, Jersey $150M AUM 7.35% 1-Year Est. Return
PIP
PB Investment Partners Burlingame, California $150M AUM 4.49% 1-Year Est. Return
AWA
AmeriServ Wealth Advisors Johnstown, Pennsylvania $150M AUM 18.14% 1-Year Est. Return
SPWM
Spartan Planning & Wealth Management Greensboro, North Carolina $150M AUM 38.04% 1-Year Est. Return
QA
Quattro Advisors Pittsburgh, Pennsylvania $150M AUM
TPW
Turn8 Private Wealth Pointe Claire $150M AUM 23.96% 1-Year Est. Return

Bridger Management's Q2 2015 Portfolio in Review

As of Q2 2015, Bridger Management held 52 positions worth $3.16B, up 111% from $1.5B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Bridger Management deployed $130M of net new capital in Q2 2015, opening 14 new positions and adding to 12 existing holdings. Its largest new stake was Boise Cascade: 1,680,672 shares worth $61.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Zoetis, an estimated $27.2M trimmed.

  • Bridger Management's largest Q2 2015 buy was Boise Cascade: 1,680,672 shares worth $61.6M.
  • Bridger Management added most to HCA Healthcare in Q2 2015, an estimated $27.1M increase.
  • Bridger Management's biggest Q2 2015 reduction was Zoetis, cutting an estimated $27.2M.
  • Bridger Management fully exited Morgan Stanley in Q2 2015, selling an estimated $71.4M.
  • Bridger Management's ten largest holdings make up 66% of its $3.16B portfolio in Q2 2015.
  • Bridger Management opened 14 new positions and closed 8 in Q2 2015.
  • Bridger Management's portfolio value rose 111% quarter-over-quarter to $3.16B.

Based on Bridger Management's 13F filing for Q2 2015, filed 14 Aug 2015.